Issues in newborn screening

Area of Science:

• Medical Genetics
• Public Health
• Neonatal Care

Background:

• Newborn screening facilitates early detection of genetic disorders to enable timely intervention and prevent severe health consequences.
• While screening programs exist globally, effective therapies are available for only a fraction of the thousands of known genetic conditions.
• Phenylketonuria (PKU) was the first disorder targeted by newborn screening, which is now implemented in 26 countries for various diseases.

Purpose of the Study:

• To evaluate the current state and challenges of newborn screening programs.
• To identify critical areas for improvement in the screening process.
• To explore the potential benefits of prenatal genetic screening and diagnostics.

Main Methods:

• Review of existing newborn screening protocols and their implementation status.
• Analysis of error rates in different phases of the screening process (pre-analytical, analytical, post-analytical).
• Discussion of challenges including quality assessment, technical competence, and ethical considerations.

Main Results:

• Significant challenges in newborn screening implementation include quality assurance, professional competence, and ethical concerns.
• The majority of errors in the screening process occur during the pre- and post-analytical phases.
• Current screening occurs post-birth, potentially delaying crucial interventions.

Conclusions:

• Enhancing pre- and post-analytical processes is vital for improving the accuracy and efficiency of newborn screening.
• Ethical considerations and technical competence require ongoing attention in program development.
• Shifting genetic screening and diagnostics to earlier in pregnancy could offer greater benefits for fetal health.